Endoscopic Joint Capsule and Articular Process Excision for the Treatment of Lumbar Facet Joint Syndrome: A Retrospective Study
Xiaoxing Tang,Hongjie Yuan,Xuehua Huang,Shilin Xiao,Yun Ji,Yanjing Zhou,Hongbo Fu,Jingfeng Lu,Mingkai Wang,Ke Ma
DOI: https://doi.org/10.2147/jpr.s471503
IF: 2.8319
2024-10-01
Journal of Pain Research
Abstract:Xiaoxing Tang, 1, &ast Hongjie Yuan, 2, &ast Xuehua Huang, 2 Shilin Xiao, 2 Yun Ji, 2 Yanjing Zhou, 1 Hongbo Fu, 3 Jingfeng Lu, 4 Mingkai Wang, 5 Ke Ma 2 1 Department of Radiology, Nantong Hospital of Traditional Chinese Medicine, Nantong, Jiangsu Province, People's Republic of China; 2 Department of Algology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China; 3 Department of Algology, Nantong Hospital of Traditional Chinese Medicine, Nantong, Jiangsu Province, People's Republic of China; 4 Department of Neurosurgery, Haian People's Hospital, Nantong, Jiangsu Province, People's Republic of China; 5 Pharmacy Department, Nantong Elderly Rehabilitation Hospital, Nantong, Jiangsu Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ke Ma, Department of Algology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, People's Republic of China, Email Background: Dorsal ramus medial branch radiofrequency ablation is reported to be effective for refractory lumbar facet joint syndrome. However, as nerve fibers can regenerate, the therapeutic effect was reported to be short and last only 6 to 12 months. Previously, we reported a novel endoscopic joint capsule and articular process excision procedure. In that case, a satisfying effect was achieved by removing the culprit hyperplastic articular synovial entrapped in the joint space endoscopically. We presume this treatment is an etiologic treatment and can exert longer-term efficacy. Aim: This retrospective clinical trial aimed to elucidate the longer-term efficacy as well as the safety profile of the procedure. Methods: This was a retrospective descriptive study. The participants underwent endoscopic joint capsule and articular process excision procedures. The Oswestry Disability Index (ODI) and Visual Analogue Scale (VAS) before the operation, and at 3 months, 6 months, 1 year, and 2 years post-operation were recorded by reviewing medical charts and conducting telephone interviews. Results: A total of 234 participants were evaluated in the trial. After participant screening, 13 participants were included in the final analysis. The VAS score was reduced from (median (P25, P75)) 6 (4.5, 6) at pre-operation to 2 (0, 4) at 1-year post-operation and 0 (0, 1) at 2-year pre-operation. The ODI score was reduced from 37.78 (27.09, 59.95) at pre-operation to 8.89 (2.22, 24.34) at 1-year post-operation and 6 (0.02, 11.11) at 2-year post-operation. The difference was statistically significant. Further subgroup analysis demonstrated that a narrowed intervertebral space was a possible relevant factor for poor outcomes. No procedure-related complications were reported. Conclusion: Endoscopic joint capsule and articular process excision is an effective and safe procedure for refractory lumbar facet joint syndrome. The effectiveness duration can last up to 1 to 2 years. Keywords: endoscopic, lumbar facet joint syndrome, synovial entrapment, joint capsule, radiofrequency, VAS, ODI Lumbar facet joint syndrome (LFJS) is acknowledged to be a multi-causal disease. Facet joint arthritis, synovial entrapment, pseudogout and facet joint cysts, etc are all involved in the pathogenesis of it. 1 Furthermore, the symptoms are diverse. Some patients experience mild chronic pain with symptoms worsening during lumbar extension or unbending the waist, while some patients experience transient sharp pain triggered by sudden change in position. In some patients, severe pain may result in compulsory position. However, the present therapeutic modalities for LFJS are mainly symptomatic treatments. The treatment of LFJS starts with physical therapy or oral medication etc., while dorsal ramus medial branch radiofrequency ablation is reserved for refractory cases. 2,3 However, the long-term efficacy of dorsal ramus medial branch radiofrequency ablation cannot be guaranteed, as the nerve fibers can regenerate. 4 The therapeutic effect was reported to last for only 6 to 12 months. 2,5,6 Previously, we had reported a novel treatment modality of endoscopic joint capsule and articular process excision (EJCE). 7 In that case, satisfying effect was achieved by removing the culprit hyperplastic articular synovial entrapped in the joint space endoscopically. We presume this treatment as an etiologic treatment and can exert longer term of efficacy. However, the previous article is merely a case report. The exact long-term -Abstract Truncated-
clinical neurology